查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1829828

2025年全球疫苗注射設備市場報告

Vaccine Delivery Devices Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，疫苗注射裝置市場規模強勁成長，從2024年的63.9億美元增加至2025年的70.1億美元，複合年成長率為9.7%。預測期內的成長可歸因於大規模脊髓灰質炎疫苗接種宣傳活動、擴大免疫規劃 (EPI)、一次性注射器的普及、天花根除工作、全球疫苗免疫聯盟 (GAVI) 以及疫苗聯盟等措施。

預計未來幾年疫苗注射裝置市場規模將強勁成長，到2029年將達到101億美元，複合年成長率為9.5%。預測期內的成長可歸因於對免疫接種計劃的日益重視、疫苗開發平臺的拓展、兒科和老年人口的成長、對低溫運輸管理的日益重視以及對預防性醫療保健措施重要性的日益認知。預測期內的主要趨勢包括疫苗注射裝置技術的持續創新、對無針解決方案的關注、個人化醫療的進步、新型自主接種疫苗以及夥伴關係的建立。

疫苗輸送裝置是為安全有效地向個人注射疫苗而設計的機製或系統。這些精密設計的工具可確保劑量精準、輸送精準，並最大程度地減少接種者的不適。這些工具在公共衛生領域的重要性在於它們能夠促進疫苗的分發和應用，並阻止感染疾病的傳播。

疫苗給藥裝置的主要類別包括無針注射系統、口服給藥系統、鼻腔給藥系統、噴射注射器、微針貼片和微注射器。無針注射系統是一種無需使用傳統針頭即可將藥物注射到皮膚中的醫療器械。它們支持多種給藥途徑，包括皮內、肌肉注射和皮下接種，並被包括醫院和診所在內的各種終端使用者所使用。

2025年春季美國關稅的突然上調及其引發的貿易摩擦對醫療設備行業產生了重大影響，尤其對用於診斷影像設備的進口零件、手術用不銹鋼和一次性塑膠製品產生了重大影響。由於醫院和診所抵制漲價，製造商面臨利潤壓力。監管挑戰使情況更加複雜，因為由於關稅而更換供應商通常需要重新認證醫療設備，導致市場進入延遲。為此，企業正在透過雙重採購關鍵零件、增加標準化產品的國內生產以及加快尋找更具成本效益的材料來降低風險。

本研究報告是商業研究公司 (The Business Research Company) 新報告系列的一部分，該系列提供疫苗輸送裝置市場統計數據，例如全球市場規模、區域佔有率、疫苗輸送裝置市場佔有率的競爭對手、詳細的疫苗輸送裝置細分市場、市場趨勢以及疫苗輸送裝置行業的商機。這些疫苗輸送裝置市場研究報告對該行業的現狀和未來趨勢進行了詳細分析，為您提供所需的一切資訊的完整展望。

我們預測未來五年該市場將成長9.5%，較我們先前對該市場的預測略有下降0.6%。下降的主要原因是美國與其他國家之間關稅的影響。這可能會直接影響美國，導致來自日本和瑞士等主要地區的微針陣列貼片和自毀式注射器的供應鏈中斷，從而導致疫苗接種延遲和疫苗接種計劃成本增加。由於互惠關稅以及貿易緊張局勢和限制加劇對全球經濟和貿易的負面影響，影響可能會更加廣泛。

感染疾病的日益普及推動了疫苗輸送裝置市場的擴張。感染疾病由各種微生物引起，包括細菌、病毒、真菌和寄生蟲，並透過各種方式傳播，包括人與人之間的接觸、動物、媒介和污染物。導致感染疾病傳播的因素包括全球旅行增加、快速都市化、氣候變遷和人口成長。疫苗輸送裝置透過有效地為人群接種疫苗、增強免疫力和抑制感染率在疾病預防中發揮著至關重要的作用。例如，根據世界衛生組織 (WHO) 2023 年 11 月的報告，2022 年全球報告了約 1,060 萬例結核病，影響了 580 萬名男性、350 萬名女性和 130 萬名兒童。因此，感染疾病的傳播正在支持疫苗輸送裝置市場的成長。

疫苗輸送裝置領域的主要企業正在透過推出預灌封注射器等產品進行創新，以提高疫苗輸送的有效性和安全性。預灌封注射器旨在安全地容納和分配預定劑量的藥物（通常為液體形式），專門用於疫苗。例如，2022年9月，美國醫療科技公司碧迪（BD）推出了BD Effivax玻璃預灌封注射器。這種先進的疫苗輸送裝置旨在透過提高疫苗接種的可靠性和效率來滿足疫苗生產不斷變化的需求。此注射器採用增強技術和更嚴格的規格，以提高填充/完成的可靠性和容器耐用性，從而降低生產中斷的風險並提高生產能力。

2022年1月，總部位於美國的輸液治療用尖端醫療設備製造商ICU Medical以未披露的金額從史密斯集團手中收購了史密斯醫療。此次收購旨在將注射器、門診輸液設備、血管通路工具和基本護理產品整合到ICU Medical的產品組合中。史密斯醫療總部位於美國，專注於疫苗輸送設備。

疫苗輸送裝置市場的主要參與者包括輝瑞、強生、默克公司、賽諾菲公司、賽諾菲公司、諾華國際股份公司、阿斯特捷利康公司、3M 公司、葛蘭素史克公司、Moderna 公司、碧迪公司 (BD)、科興生物技術有限公司、CSL 有限公司、INOVIO 公司、Terumo Corporation 、CSL 有限公司、BVrian Adici， Corporation、康希諾生物股份公司、Vaxxas 公司、PharmaJet 公司、Enesi Pharma 有限公司、NanoPass Technologies 有限公司、Gerresheimer 股份公司和 Panacea Biotec 有限公司。

2024年，北美是疫苗輸送裝置市場最大的地區。預計亞太地區將成為預測期內成長最快的地區。疫苗輸送裝置市場報告涵蓋亞太地區、西歐、中歐和東歐、北美、南美以及中東和非洲。

疫苗注射裝置市場報告涵蓋的國家有澳洲、巴西、中國、法國、德國、印度、印尼、日本、美國、韓國、英國、英國、加拿大、義大利和西班牙。

疫苗輸送裝置市場包括噴射注射器、自動注射器、口服疫苗輸送裝置、微針貼片、經皮吸收貼片、吸入器和皮內注射裝置的銷售。該市場的價值為“出廠價”，即商品製造商或生產商向其他營業單位（包括下游製造商、批發商、經銷商和零售商）或直接向最終客戶銷售的商品價值。該市場中的商品價值還包括商品製造商銷售的任何相關服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球疫苗接種設備：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 最終用途產業分析
  • 全球疫苗輸送裝置市場：成長率分析
  • 全球疫苗注射裝置市場表現：規模與成長，2019-2024
  • 全球疫苗注射裝置市場預測：規模與成長，2024-2029 年，2034 年
  • 全球疫苗接種設備：總目標市場（TAM）

第6章 市場細分

  • 全球疫苗注射設備市場（依設備類型、實際及預測），2019-2024 年、2024-2029 年、2034 年
  • 無針注射系統
  • 口服給藥系統
  • 鼻腔給藥系統
  • 噴射注射器
  • 微針貼片和微注射器
  • 全球疫苗注射裝置市場（依給藥途徑）：2019-2024 年、2024-2029 年、2034 年實際資料及預測
  • 皮內接種
  • 肌肉注射疫苗
  • 皮下接種
  • 其他疫苗
  • 全球疫苗注射裝置市場：按最終用戶、實際和預測，2019-2024 年、2024-2029 年、2034 年
  • 醫院
  • 診所
  • 其他最終用戶
  • 全球疫苗注射裝置市場：按無針注射系統細分（按類型）、實際和預測，2019-2024 年、2024-2029 年、2034 年
  • 基於 Spring 的注入器
  • 氣動噴射器
  • 混合噴油器
  • 全球疫苗給藥裝置市場：按口服給藥系統細分（按類型）、實際及預測，2019-2024 年、2024-2029 年、2034 年
  • 口服片劑和膠囊
  • 口腔噴霧劑
  • 口服溶液
  • 全球疫苗給藥裝置市場：依鼻腔給藥系統細分（按類型）、實際及預測，2019-2024 年、2024-2029 年、2034 年
  • 鼻噴劑
  • 滴鼻劑
  • 鼻粉系統
  • 全球疫苗輸送裝置市場：噴射注射器細分市場（按類型）、實際及預測，2019-2024 年、2024-2029 年、2034 年
  • 氣動噴射注射器
  • 電子機械噴射注射器
  • 全球疫苗輸送裝置市場：按類型細分：微針貼片和微注射器，實際和預測，2019-2024 年、2024-2029 年、2034 年
  • 可溶解微針
  • 實心微針
  • 顯微注射裝置

第7章 區域和國家分析

  • 全球疫苗注射裝置市場：區域分析、預測與成長，2019-2024 年、2024-2029 年、2034 年
  • 全球疫苗注射裝置市場：國家、現況及預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 疫苗輸送裝置市場：競爭格局
  • 疫苗輸送裝置市場：公司簡介
    • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
    • Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Sanofi SA Overview, Products and Services, Strategy and Financial Analysis
    • Novartis International AG Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

  • AstraZeneca PLC
  • 3M Company
  • GlaxoSmithKline plc
  • Moderna Inc.
  • Becton Dickinson and Company（BD）
  • Sinovac Biotech Co. Ltd.
  • CSL Limited
  • INOVIO Pharmaceuticals Inc.
  • Terumo Corporation
  • SCHOTT AG
  • Serum Institute of India Pvt. Ltd.
  • Bavarian Nordic A/S
  • Dynavax Technologies Corporation
  • CanSino Biologics Inc.
  • Vaxxas Inc.

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章：高潛力市場國家、細分市場與策略

  • 2029年疫苗注射裝置市場：提供新機會的國家
  • 2029年疫苗注射裝置市場：細分市場將帶來新機會
  • 2029年疫苗注射設備市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r31459u

Vaccine delivery devices are mechanisms or systems devised to safely and efficiently administer vaccines to individuals. Engineered with precision, these tools guarantee precise dosage, accurate delivery, and minimal discomfort for the recipient. Their significance in public health endeavors lies in their ability to facilitate the distribution and application of vaccines, thereby thwarting the spread of infectious diseases.

The primary categories of vaccine delivery devices comprise needle-free injection systems, oral delivery systems, nasal delivery systems, jet injectors, microneedle patches, and microinjectors. Needle-free injection systems are medical tools designed to administer medication into the skin without employing a conventional needle. They facilitate various routes of administration, including intradermal, intramuscular, and subcutaneous vaccination, and are utilized by a range of end-users, including hospitals and clinics.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The vaccine delivery devices market research report is one of a series of new reports from The Business Research Company that provides vaccine delivery devices market statistics, including the vaccine delivery devices industry global market size, regional shares, competitors with vaccine delivery devices market share, detailed vaccine delivery devices market segments, market trends, and opportunities, and any further data you may need to thrive in the vaccine delivery devices industry. These vaccine delivery devices market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The vaccine delivery devices market size has grown strongly in recent years. It will grow from $6.39 billion in 2024 to $7.01 billion in 2025 at a compound annual growth rate (CAGR) of 9.7%. The growth in the historic period can be attributed to large-scale polio vaccination campaigns, expanded program on immunization (EPI), the adoption of disposable syringes, smallpox eradication efforts, initiatives including the global alliance for vaccines and immunization (GAVI) and the vaccine alliance.

The vaccine delivery devices market size is expected to see strong growth in the next few years. It will grow to $10.1 billion in 2029 at a compound annual growth rate (CAGR) of 9.5%. The growth in the forecast period can be attributed to the growing emphasis on immunization programs, expanded vaccine development pipelines, expanding pediatric and geriatric populations, focus on cold chain management, and raising awareness about the importance of preventive healthcare measures. Major trends in the forecast period include the continued innovations in vaccine delivery device technology, focus on needle-free solutions, advancements in personalized medicine, new self-administered vaccines, and the partnerships.

The forecast of 9.5% growth over the next five years reflects a modest reduction of 0.6% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through supply chain disruptions for microneedle array patches and auto-disable syringe mechanisms, sourced from key regions such as Japan and Switzerland, could lead to immunization delays and higher vaccination program costs.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The rise in infectious diseases prevalence is poised to drive the expansion of the vaccine delivery devices market. Infectious diseases, caused by various microorganisms such as bacteria, viruses, fungi, or parasites, spread through various means including person-to-person contact, animals, vectors, or contaminated substances. Factors contributing to the prevalence of infectious diseases include increased global travel, rapid urbanization, shifts in climate patterns, and population expansion. Vaccine delivery devices play a pivotal role in disease prevention by effectively administering vaccines to populations, bolstering immunity, and curbing transmission rates. For instance, as reported by the World Health Organization (WHO) in November 2023, approximately 10.6 million cases of tuberculosis (TB) were reported worldwide in 2022, impacting 5.8 million men, 3.5 million women, and 1.3 million children. Consequently, the pervasive presence of infectious diseases underpins the growth of the vaccine delivery devices market.

Major companies in the vaccine delivery devices sector are innovating by introducing products such as prefillable syringes to improve the effectiveness and safety of vaccine delivery. Prefillable syringes are designed to securely contain and dispense a predetermined dosage of medication, typically in liquid form, specifically for vaccines. For example, in September 2022, Becton, Dickinson, and Company (BD), a US-based medical technology firm, launched the BD Effivax Glass Prefillable Syringe. This advanced vaccine delivery device aims to address the evolving requirements of vaccine production by enhancing reliability and efficiency in vaccine administration. The syringe incorporates enhanced technology and stricter specifications to provide increased fill or finish reliability and container durability, thereby reducing the risk of production interruptions and enhancing manufacturing capabilities.

In January 2022, ICU Medical Inc., a US-based producer of cutting-edge medical equipment utilized in infusion therapy, purchased Smiths Medical from Smiths Group plc for an undisclosed sum. This acquisition was aimed at integrating syringe and ambulatory infusion devices, vascular access tools, and essential care products into ICU Medical's range. Smiths Medical, a US-based company, specializes in vaccine delivery devices.

Major companies operating in the vaccine delivery devices market are Pfizer Inc., Johnson & Johnson, Merck & Co. Inc., Sanofi S.A., Novartis International AG, AstraZeneca PLC, 3M Company, GlaxoSmithKline plc, Moderna Inc., Becton Dickinson and Company (BD), Sinovac Biotech Co. Ltd., CSL Limited, INOVIO Pharmaceuticals Inc., Terumo Corporation, SCHOTT AG, Serum Institute of India Pvt. Ltd., Bavarian Nordic A/S, Dynavax Technologies Corporation, CanSino Biologics Inc., Vaxxas Inc., PharmaJet Inc., Enesi Pharma Limited, NanoPass Technologies Ltd., Gerresheimer AG, Panacea Biotec Limited

North America was the largest region in the vaccine delivery devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the vaccine delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the vaccine delivery devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The vaccine delivery devices market consists of sales of jet injectors, auto-injectors, oral vaccine delivery, microneedle patches, transdermal patches, inhalers, and intradermal devices. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Vaccine Delivery Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on vaccine delivery devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for vaccine delivery devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The vaccine delivery devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type Of Device: Needle Free Injection Systems; Oral Delivery Systems; Nasal Delivery Systems; Jet Injectors; Microneedle Patches And Microinjectors
  • 2) By Route Of Administration: Intradermal Vaccination; Intramuscular Vaccination; Subcutaneous Vaccination; Other Vaccinations
  • 3) By End Users: Hospitals; Clinics; Other End Users
  • Subsegments:
  • 1) By Needle Free Injection Systems: Spring-Based Injectors; Gas-Driven Injectors; Hybrid Injectors
  • 2) By Oral Delivery Systems: Oral Tablets And Capsules; Oral Sprays; Oral Solutions
  • 3) By Nasal Delivery Systems: Nasal Sprays; Nasal Drops; Nasal Powder Systems
  • 4) By Jet Injectors: Pneumatic Jet Injectors; Electromechanical Jet Injectors
  • 5) By Microneedle Patches And Microinjectors: Dissolvable Microneedles; Solid Microneedles; Microinjector Devices
  • Companies Mentioned: Pfizer Inc.; Johnson & Johnson; Merck & Co. Inc.; Sanofi S.A.; Novartis International AG; AstraZeneca PLC; 3M Company; GlaxoSmithKline plc; Moderna Inc.; Becton Dickinson and Company (BD); Sinovac Biotech Co. Ltd.; CSL Limited; INOVIO Pharmaceuticals Inc.; Terumo Corporation; SCHOTT AG; Serum Institute of India Pvt. Ltd.; Bavarian Nordic A/S; Dynavax Technologies Corporation; CanSino Biologics Inc.; Vaxxas Inc.; PharmaJet Inc.; Enesi Pharma Limited; NanoPass Technologies Ltd.; Gerresheimer AG; Panacea Biotec Limited
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Vaccine Delivery Devices Market Characteristics

3. Vaccine Delivery Devices Market Trends And Strategies

4. Vaccine Delivery Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Vaccine Delivery Devices Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Vaccine Delivery Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Vaccine Delivery Devices Market Growth Rate Analysis
  • 5.4. Global Vaccine Delivery Devices Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Vaccine Delivery Devices Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Vaccine Delivery Devices Total Addressable Market (TAM)

6. Vaccine Delivery Devices Market Segmentation

  • 6.1. Global Vaccine Delivery Devices Market, Segmentation By Type Of Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Needle Free Injection Systems
  • Oral Delivery Systems
  • Nasal Delivery Systems
  • Jet Injectors
  • Microneedle Patches And Microinjectors
  • 6.2. Global Vaccine Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Intradermal Vaccination
  • Intramuscular Vaccination
  • Subcutaneous Vaccination
  • Other Vaccinations
  • 6.3. Global Vaccine Delivery Devices Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Clinics
  • Other End Users
  • 6.4. Global Vaccine Delivery Devices Market, Sub-Segmentation Of Needle Free Injection Systems, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Spring-Based Injectors
  • Gas-Driven Injectors
  • Hybrid Injectors
  • 6.5. Global Vaccine Delivery Devices Market, Sub-Segmentation Of Oral Delivery Systems, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Oral Tablets And Capsules
  • Oral Sprays
  • Oral Solutions
  • 6.6. Global Vaccine Delivery Devices Market, Sub-Segmentation Of Nasal Delivery Systems, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Nasal Sprays
  • Nasal Drops
  • Nasal Powder Systems
  • 6.7. Global Vaccine Delivery Devices Market, Sub-Segmentation Of Jet Injectors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Pneumatic Jet Injectors
  • Electromechanical Jet Injectors
  • 6.8. Global Vaccine Delivery Devices Market, Sub-Segmentation Of Microneedle Patches And Microinjectors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Dissolvable Microneedles
  • Solid Microneedles
  • Microinjector Devices

7. Vaccine Delivery Devices Market Regional And Country Analysis

  • 7.1. Global Vaccine Delivery Devices Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Vaccine Delivery Devices Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Vaccine Delivery Devices Market

  • 8.1. Asia-Pacific Vaccine Delivery Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Vaccine Delivery Devices Market, Segmentation By Type Of Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Vaccine Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Vaccine Delivery Devices Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Vaccine Delivery Devices Market

  • 9.1. China Vaccine Delivery Devices Market Overview
  • 9.2. China Vaccine Delivery Devices Market, Segmentation By Type Of Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Vaccine Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Vaccine Delivery Devices Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Vaccine Delivery Devices Market

  • 10.1. India Vaccine Delivery Devices Market, Segmentation By Type Of Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Vaccine Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Vaccine Delivery Devices Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Vaccine Delivery Devices Market

  • 11.1. Japan Vaccine Delivery Devices Market Overview
  • 11.2. Japan Vaccine Delivery Devices Market, Segmentation By Type Of Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Vaccine Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Vaccine Delivery Devices Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Vaccine Delivery Devices Market

  • 12.1. Australia Vaccine Delivery Devices Market, Segmentation By Type Of Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Vaccine Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Vaccine Delivery Devices Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Vaccine Delivery Devices Market

  • 13.1. Indonesia Vaccine Delivery Devices Market, Segmentation By Type Of Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Vaccine Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Vaccine Delivery Devices Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Vaccine Delivery Devices Market

  • 14.1. South Korea Vaccine Delivery Devices Market Overview
  • 14.2. South Korea Vaccine Delivery Devices Market, Segmentation By Type Of Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Vaccine Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Vaccine Delivery Devices Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Vaccine Delivery Devices Market

  • 15.1. Western Europe Vaccine Delivery Devices Market Overview
  • 15.2. Western Europe Vaccine Delivery Devices Market, Segmentation By Type Of Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Vaccine Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Vaccine Delivery Devices Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Vaccine Delivery Devices Market

  • 16.1. UK Vaccine Delivery Devices Market, Segmentation By Type Of Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Vaccine Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Vaccine Delivery Devices Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Vaccine Delivery Devices Market

  • 17.1. Germany Vaccine Delivery Devices Market, Segmentation By Type Of Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Vaccine Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Vaccine Delivery Devices Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Vaccine Delivery Devices Market

  • 18.1. France Vaccine Delivery Devices Market, Segmentation By Type Of Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Vaccine Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Vaccine Delivery Devices Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Vaccine Delivery Devices Market

  • 19.1. Italy Vaccine Delivery Devices Market, Segmentation By Type Of Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Vaccine Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Vaccine Delivery Devices Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Vaccine Delivery Devices Market

  • 20.1. Spain Vaccine Delivery Devices Market, Segmentation By Type Of Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Vaccine Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Vaccine Delivery Devices Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Vaccine Delivery Devices Market

  • 21.1. Eastern Europe Vaccine Delivery Devices Market Overview
  • 21.2. Eastern Europe Vaccine Delivery Devices Market, Segmentation By Type Of Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Vaccine Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Vaccine Delivery Devices Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Vaccine Delivery Devices Market

  • 22.1. Russia Vaccine Delivery Devices Market, Segmentation By Type Of Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Vaccine Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Vaccine Delivery Devices Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Vaccine Delivery Devices Market

  • 23.1. North America Vaccine Delivery Devices Market Overview
  • 23.2. North America Vaccine Delivery Devices Market, Segmentation By Type Of Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Vaccine Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Vaccine Delivery Devices Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Vaccine Delivery Devices Market

  • 24.1. USA Vaccine Delivery Devices Market Overview
  • 24.2. USA Vaccine Delivery Devices Market, Segmentation By Type Of Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Vaccine Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Vaccine Delivery Devices Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Vaccine Delivery Devices Market

  • 25.1. Canada Vaccine Delivery Devices Market Overview
  • 25.2. Canada Vaccine Delivery Devices Market, Segmentation By Type Of Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Vaccine Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Vaccine Delivery Devices Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Vaccine Delivery Devices Market

  • 26.1. South America Vaccine Delivery Devices Market Overview
  • 26.2. South America Vaccine Delivery Devices Market, Segmentation By Type Of Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Vaccine Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Vaccine Delivery Devices Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Vaccine Delivery Devices Market

  • 27.1. Brazil Vaccine Delivery Devices Market, Segmentation By Type Of Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Vaccine Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Vaccine Delivery Devices Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Vaccine Delivery Devices Market

  • 28.1. Middle East Vaccine Delivery Devices Market Overview
  • 28.2. Middle East Vaccine Delivery Devices Market, Segmentation By Type Of Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Vaccine Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Vaccine Delivery Devices Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Vaccine Delivery Devices Market

  • 29.1. Africa Vaccine Delivery Devices Market Overview
  • 29.2. Africa Vaccine Delivery Devices Market, Segmentation By Type Of Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Vaccine Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Vaccine Delivery Devices Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Vaccine Delivery Devices Market Competitive Landscape And Company Profiles

  • 30.1. Vaccine Delivery Devices Market Competitive Landscape
  • 30.2. Vaccine Delivery Devices Market Company Profiles
    • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Novartis International AG Overview, Products and Services, Strategy and Financial Analysis

31. Vaccine Delivery Devices Market Other Major And Innovative Companies

  • 31.1. AstraZeneca PLC
  • 31.2. 3M Company
  • 31.3. GlaxoSmithKline plc
  • 31.4. Moderna Inc.
  • 31.5. Becton Dickinson and Company (BD)
  • 31.6. Sinovac Biotech Co. Ltd.
  • 31.7. CSL Limited
  • 31.8. INOVIO Pharmaceuticals Inc.
  • 31.9. Terumo Corporation
  • 31.10. SCHOTT AG
  • 31.11. Serum Institute of India Pvt. Ltd.
  • 31.12. Bavarian Nordic A/S
  • 31.13. Dynavax Technologies Corporation
  • 31.14. CanSino Biologics Inc.
  • 31.15. Vaxxas Inc.

32. Global Vaccine Delivery Devices Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Vaccine Delivery Devices Market

34. Recent Developments In The Vaccine Delivery Devices Market

35. Vaccine Delivery Devices Market High Potential Countries, Segments and Strategies

  • 35.1 Vaccine Delivery Devices Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Vaccine Delivery Devices Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Vaccine Delivery Devices Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer